Literature DB >> 20364082

Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development.

Fu-Jung Lin1, Xinpu Chen, Jun Qin, Young-Kwon Hong, Ming-Jer Tsai, Sophia Y Tsai.   

Abstract

The lymphatic system plays a key role in tissue fluid homeostasis. Lymphatic dysfunction contributes to the pathogenesis of many human diseases, including lymphedema and tumor metastasis. However, the mechanisms regulating lymphangiogenesis remain largely unknown. Here, we show that COUP-TFII (also known as Nr2f2), an orphan member of the nuclear receptor superfamily, mediates both developmental and pathological lymphangiogenesis in mice. Conditional ablation of COUP-TFII at an early embryonic stage resulted in failed formation of pre-lymphatic ECs (pre-LECs) and lymphatic vessels. COUP-TFII deficiency at a late developmental stage resulted in loss of LEC identity, gain of blood EC fate, and impaired lymphatic vessel sprouting. siRNA-mediated downregulation of COUP-TFII in cultured primary human LECs demonstrated that the maintenance of lymphatic identity and VEGF-C-induced lymphangiogenic activity, including cell proliferation and migration, are COUP-TFII-dependent and cell-autonomous processes. COUP-TFII enhanced the pro-lymphangiogenic actions of VEGF-C, at least in part by directly stimulating expression of neuropilin-2, a coreceptor for VEGF-C. In addition, COUP-TFII inactivation in a mammary gland mouse tumor model resulted in inhibition of tumor lymphangiogenesis, suggesting that COUP-TFII also regulates neo-lymphangiogenesis in the adult. Thus, COUP-TFII is a critical factor that controls lymphangiogenesis in embryonic development and tumorigenesis in adults.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20364082      PMCID: PMC2860940          DOI: 10.1172/JCI40101

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.

Authors:  M J Karkkainen; R E Ferrell; E C Lawrence; M A Kimak; K L Levinson; M A McTigue; K Alitalo; D N Finegold
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

Review 2.  Lymphangiogenesis in development and human disease.

Authors:  Kari Alitalo; Tuomas Tammela; Tatiana V Petrova
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

3.  Live imaging of lymphatic development in the zebrafish.

Authors:  Karina Yaniv; Sumio Isogai; Daniel Castranova; Louis Dye; Jiro Hitomi; Brant M Weinstein
Journal:  Nat Med       Date:  2006-05-28       Impact factor: 53.440

4.  Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes.

Authors:  Carl de Luca; Timothy J Kowalski; Yiying Zhang; Joel K Elmquist; Charlotte Lee; Manfred W Kilimann; Thomas Ludwig; Shun-Mei Liu; Streamson C Chua
Journal:  J Clin Invest       Date:  2005-11-10       Impact factor: 14.808

5.  Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation.

Authors:  Tohru Morisada; Yuichi Oike; Yoshihiro Yamada; Takashi Urano; Masaki Akao; Yoshiaki Kubota; Hiromitsu Maekawa; Yoshishige Kimura; Masako Ohmura; Takeshi Miyamoto; Shiro Nozawa; Gou Young Koh; Kari Alitalo; Toshio Suda
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

6.  Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity.

Authors:  Li-Ru You; Fu-Jung Lin; Christopher T Lee; Francesco J DeMayo; Ming-Jer Tsai; Sophia Y Tsai
Journal:  Nature       Date:  2005-05-05       Impact factor: 49.962

7.  Angiopoietin-1 promotes lymphatic sprouting and hyperplasia.

Authors:  Tuomas Tammela; Anne Saaristo; Marja Lohela; Tohru Morisada; Jenny Tornberg; Camilla Norrmén; Yuichi Oike; Katri Pajusola; Gavin Thurston; Toshio Suda; Seppo Yla-Herttuala; Kari Alitalo
Journal:  Blood       Date:  2005-03-03       Impact factor: 22.113

8.  Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization.

Authors:  Michael Potente; Carmen Urbich; Ken-ichiro Sasaki; Wolf K Hofmann; Christopher Heeschen; Alexandra Aicher; Ramya Kollipara; Ronald A DePinho; Andreas M Zeiher; Stefanie Dimmeler
Journal:  J Clin Invest       Date:  2005-08-11       Impact factor: 14.808

9.  Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor.

Authors:  JianMin Lin; Alshad S Lalani; Thomas C Harding; Melissa Gonzalez; Wei-Wei Wu; Bo Luan; Guang Huan Tu; Kathryn Koprivnikar; Melinda J VanRoey; Yulong He; Kari Alitalo; Karin Jooss
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

10.  Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.

Authors:  Nicole Roberts; Bryan Kloos; Melanie Cassella; Simona Podgrabinska; Kris Persaud; Yan Wu; Bronislaw Pytowski; Mihaela Skobe
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

View more
  66 in total

1.  COUP-TFII is essential for metanephric mesenchyme formation and kidney precursor cell survival.

Authors:  Cheng-Tai Yu; Ke Tang; Jae Mi Suh; Rulang Jiang; Sophia Y Tsai; Ming-Jer Tsai
Journal:  Development       Date:  2012-07       Impact factor: 6.868

Review 2.  The new era of the lymphatic system: no longer secondary to the blood vascular system.

Authors:  Inho Choi; Sunju Lee; Young-Kwon Hong
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

3.  Chicken ovalbumin upstream promoter transcription factor II regulates renin gene expression.

Authors:  Sandra Mayer; Marc Roeser; Peter Lachmann; Sumiyashi Ishii; Jae Mi Suh; Sabine Harlander; Michael Desch; Coy Brunssen; Henning Morawietz; Sophia Y Tsai; Ming-Jer Tsai; Bernd Hohenstein; Christian Hugo; Vladimir T Todorov
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

4.  VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancer.

Authors:  Hira Lal Goel; Cheng Chang; Bryan Pursell; Irwin Leav; Stephen Lyle; Hualin Simon Xi; Chung-Cheng Hsieh; Helty Adisetiyo; Pradip Roy-Burman; Ilsa M Coleman; Peter S Nelson; Robert L Vessella; Roger J Davis; Stephen R Plymate; Arthur M Mercurio
Journal:  Cancer Discov       Date:  2012-07-09       Impact factor: 39.397

Review 5.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

Review 6.  Rostro-Caudal and Caudo-Rostral Migrations in the Telencephalon: Going Forward or Backward?

Authors:  Nuria Ruiz-Reig; Michèle Studer
Journal:  Front Neurosci       Date:  2017-12-21       Impact factor: 4.677

7.  Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling.

Authors:  Jun Qin; Xinpu Chen; Li-Yuan Yu-Lee; Ming-Jer Tsai; Sophia Y Tsai
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

8.  A role for BRG1 in the regulation of genes required for development of the lymphatic system.

Authors:  Ajeet Pratap Singh; Julie Foley; Arpit Tandon; Dhiral Phadke; H Karimi Kinyamu; Trevor K Archer
Journal:  Oncotarget       Date:  2017-07-04

9.  Notch1 functions as a negative regulator of lymphatic endothelial cell differentiation in the venous endothelium.

Authors:  Aino Murtomaki; Minji K Uh; Yun K Choi; Christopher Kitajewski; Valeriya Borisenko; Jan Kitajewski; Carrie J Shawber
Journal:  Development       Date:  2013-04-24       Impact factor: 6.868

Review 10.  Choose your destiny: Make a cell fate decision with COUP-TFII.

Authors:  San-Pin Wu; Cheng-Tai Yu; Sophia Y Tsai; Ming-Jer Tsai
Journal:  J Steroid Biochem Mol Biol       Date:  2015-12-02       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.